ID: ALA3221864

Max Phase: Preclinical

Molecular Formula: C29H36N4O5

Molecular Weight: 520.63

Molecule Type: Small molecule

Representations

Canonical SMILES:  COCCc1cc(COc2ccc([C@]3(N)CCN([C@H](CC(C)C)C(=O)NO)C3=O)cc2)c2ccccc2n1

Standard InChI:  InChI=1S/C29H36N4O5/c1-19(2)16-26(27(34)32-36)33-14-13-29(30,28(33)35)21-8-10-23(11-9-21)38-18-20-17-22(12-15-37-3)31-25-7-5-4-6-24(20)25/h4-11,17,19,26,36H,12-16,18,30H2,1-3H3,(H,32,34)/t26-,29-/m1/s1

Standard InChI Key:  OKHKINWJYOOKOF-GGXMVOPNSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 520.63

Molecular Weight (Monoisotopic): 520.2686

AlogP: 3.31

#Rotatable Bonds: 11

Polar Surface Area: 127.01

Molecular Species: NEUTRAL

HBA: 7

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 9

HBD (Lipinski): 4

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 8.74

CX Basic pKa: 7.46

CX LogP: 2.62

CX LogD: 2.44

Aromatic Rings: 3

Heavy Atoms: 38

QED Weighted: 0.26

Np Likeness Score: -0.37

References

1. Argade A, Bahekar R, Desai J, Thombare P, Shah K, Gite S, Sunder R, Ranvir R, Bandyopadhyay D, Chakrabarti G, Joharapurkar A, Mahapatra J, Chatterjee A, Patel H, Shaikh M, Sairam KVVM, Jain M, Patel P.  (2011)  Design, synthesis and biological evaluation of -lactam hydroxamate based TACE inhibitors,  2  (10): [10.1039/C0MD00261E]

Source

Source(1):

• Scientific Literature